S
Spotlight Surgical
A San Francisco-based developer of medical visualization software
About Spotlight Surgical
Spotlight Medical is a precision medicine firm operating at the intersection of artificial intelligence and oncology. Established in 2024 and headquartered in Paris, France, the company is focused on developing advanced prognosis tests to guide physicians in selecting optimal cancer treatments. The core of its business is a platform that leverages AI algorithms to analyze vast sets of patient data, aiming to provide insights that prevent both over-treatment and under-treatment of cancer patients.
The company was founded by CEO Sylvain Berlemont. From its inception, Spotlight Medical has garnered significant support from the medical community, backed by internationally recognized cancer centers, the Institut Curie and Gustave Roussy. This collaboration provides a strong clinical foundation for its technology development. The business model is centered on the commercialization of these AI-driven clinical tests, which will be offered to healthcare providers and cancer treatment centers.
In a significant milestone for the young company, Spotlight Medical secured €6.2 million in a seed funding round in July 2024. The investment was co-led by venture capital firms Kurma Partners and Heal Capital. This infusion of capital is earmarked to advance its first prognosis test into clinical use, a critical step toward commercialization and making a tangible impact on patient outcomes. The company’s approach seeks to provide a concrete AI-based solution to enhance the precision of cancer therapy.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2004
- Headquarters
- San Francisco, United States
- Open positions
- None listed
- Dealroom signal
- 19.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Oncology, Surgery, Surgical Equipment, Clinical Decision Support, AI for medical imaging, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Feb 2015 | $23M | $92M | Undisclosed | — |
| LATE VCOther financing | Feb 2014 | $22M | $90M | Undisclosed | — |
Growth signals
Latest recorded traffic for Spotlight Surgical is 90 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- AVAttractor Ventures
Attractor
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Spotlight Surgical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Spotlight Surgical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.